Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
When a serious illness enters a family's life, there are many questions to ask and decisions to make. It is important to answer these questions quickly. The process can seem overwhelming. However, hospice care can be a wonderful resource for information about symptom management and comfort care. Hospice care professionals are available to help assess goals, pain management and care options during the decision-making process.
Are your symptoms minimal or moderate? Are these symptoms just starting to affect your life? If you want to continue treatment but also need comfort and symptom management, palliative care (often called comfort care) maybe an option. Palliative care is patient and family-centered care that optimizes quality of life by anticipating, preventing and treating suffering. Palliative care specialists address the physical, intellectual, emotional, social, and spiritual needs of patients and families, making sure they have access to all the information about the disease progression and the choices ahead. A patient can receive palliative care in conjunction with other treatments or therapies.
To view the multimedia release go to:
http://www.multivu.com/players/English/7429131-moments-of-life-by-hospice/
At Munich’s real estate exhibition last week, Russia’s leading e-commerce company, Ulmart, hosted a “working breakfast” to discuss the nuances and intricacies of investing in Russia today during times of heightened international tension.
The topic, “Making the Case for Star Investment Projects in Russia”, featured Ulmart’s chairman and majority shareholder Dmitry Kostygin; Andrew Kaye, Managing Director and Co-Head of Technology Banking, William Blair International; Calin Anton Business Development Director Russia & CIS, Astron; and, Tim Millard, Regional Director, Head of Consulting Services at Jones Lang LaSalle, Russia.
A lively discussion kicked off about how some in the investment community tend to focus—even obsess—on macro realties at a state-to-state level ignoring many truly interesting project; precisely the types of projects that keep most of the world’s economies developing positively from cycle to cycle.
To view the multimedia release go to:
http://www.multivu.com/players/English/7660751-ulmart-russian-investment-update/
At Munich’s real estate exhibition last week, Russia’s leading e-commerce company, Ulmart, hosted a “working breakfast” to discuss the nuances and intricacies of investing in Russia today during times of heightened international tension.
The topic, “Making the Case for Star Investment Projects in Russia”, featured Ulmart’s chairman and majority shareholder Dmitry Kostygin; Andrew Kaye, Managing Director and Co-Head of Technology Banking, William Blair International; Calin Anton Business Development Director Russia & CIS, Astron; and, Tim Millard, Regional Director, Head of Consulting Services at Jones Lang LaSalle, Russia.
A lively discussion kicked off about how some in the investment community tend to focus—even obsess—on macro realties at a state-to-state level ignoring many truly interesting project; precisely the types of projects that keep most of the world’s economies developing positively from cycle to cycle.
To view the multimedia release go to:
http://www.multivu.com/players/English/7660751-ulmart-russian-investment-update/
The 6th Beijing Biennale under the theme of “Memory and Dream”, co-sponsored by the China Federation of Literary and Art Circles, the People’s Government of Beijing Municipality and the China Artists Association is expected to be exhibited in the National Art Museum of China from Sep.24 to Oct.15, 2015. The exhibition attracted 685 pieces of artwork from 96 countries which registered half of the member countries of the United Nations, covering contemporary paintings, sculptures, installations, videos and mixed media (with 188 pieces of artwork from China and 497 pieces of artwork from foreign countries).
Artists from all over the world were encouraged to create paintings and sculptures related to the theme “Memory and Dream”. The International Art Gala with unprecedented size of participating countries provides a high standard visual feast for all art lovers from all over the world. Beijing Biennale serves as a platform to demonstrate historical and cultural memories of different countries and express humankind’s expectation and aspiration for the future by means of art. Following the opening ceremony, the Beijing Biennale has become the focus of audiences and media with the daily volume registered at 7000. It is expected that during the Golden Week of the National Holiday, the audiences per day will amount to more than 10,000.
To view the multimedia release go to:
http://www.multivu.com/players/English/7644351-beijing-biennale-memory-and-dream/
October is National Plan a Cruise Month and the cruise industry is celebrating by launching #CruiseSmile, a simple and exciting chance to win one of 31 cruise vacations from 23 different cruise lines awarded each day, from October 1 through October 31, 2015. Anyone can enter each day during the sweepstakes by simply submitting a photo featuring a ‘cruise smile’ at CruiseSmile.org, or posting their ‘cruise smile’ on Twitter or Instagram using #CruiseSmile and #Sweepstakes. Participants will have the opportunity to share their posts for more chances to win.
“Those who cruise have a secret: they love cruising and cannot stop smiling about it. Whether it's planning, booking, dreaming about or basking in the memories of taking a cruise vacation, it's hard not to smile,” said Cindy D'Aoust, Acting CEO, Cruise Lines International Association (CLIA). “The #CruiseSmile campaign is a fun way for the cruise industry to spread the love of cruising during National Plan a Cruise Month as well give vacation dreamers the chance to win a remarkable cruise vacation for two.”
The #CruiseSmile sweepstakes prize calendar is filled with incredible cruise vacations for two, including a seven-night luxury voyage to Tahiti and the Society Islands in the South Pacific, an eight-day European river cruise on the Seine River from Paris, a magical family-friendly three-night Bahamian voyage at sea and even a 14-day Far-East Discovery cruise visiting exotic ports throughout Southeast Asia.
To view the multimedia release go to:
http://www.multivu.com/players/English/7584131-clia-national-plan-a-cruise-month/
Employers around the world can now take the pulse of the labor market in less than a minute thanks to CEB (NYSE: CEB), a best practice insight and technology company, and its new Global Talent Monitor. The company launched the tool today to hundreds of talent executives during its ReimagineHR summit in Chicago, Ill.
CEB’s Global Talent Monitor provides a snapshot of how real employees and job candidates around the world feel about the economy, their own prospects and what motivates them—or doesn’t—when it comes to work. By keying in on six metrics, CEB provides employers topline visibility into employees’ needs and motivations, which help them focus priorities and shape programs based on business need.
To view the multimedia release go to:
http://www.multivu.com/players/English/7427251-ceb-global-talent-monitor/
On the eve of National Adopt-A-Dog Month, the network is getting into some heavy petting. That’s when dogs and cats will invade the channel to launch MTV2’s #Down2Adopt, an on-air and online campaign to make shelters and rescue groups the go-to choice when looking for your new best friend. MTV2 will showcase adoptable shelter and rescue pets during the year-long campaign as they join forces with The Shelter Pet Project, a national public service program from the Ad Council, The Humane Society of the United States and Maddie’s Fund®.
#Down2Adopt launches with a series of video pet biographies featuring the voices of Kristen Bell, MTV2’s Charlamagne Tha God and MTV2’s Carly Aquilino comically narrating stories of how some dogs and cats found themselves in shelters. It will be all paws on deck when the #Down2Adopt pet bios premiere during an all new episode of MTV2’s “Uncommon Sense with Charlamagne” tonight, Wednesday, September 30, at 11pm ET. Charlamagne and guests including Vinny Guadagnino will share why they’re down to adopt shelter pets and will hang with Charm, an adoptable puppy from St. Hubert’s Animal Welfare Center in New Jersey.
To view the multimedia release go to:
http://www.multivu.com/players/English/7606951-ad-council-mtv2-adopt-a-dog-month/
Globally renowned tennis champion and Supergoop! Co-Owner Maria Sharapova alongside Supergoop! Founder & CEO Holly Thaggard, are proud to announce the launch of Project Black Dot, a new education and activism platform with the singular mission to end the epidemic of skin cancer and improve skin health in America. Maria is the face and champion of this multidimensional platform that focuses on providing consumers with suncare education and activations year round, not just during the traditional “sun” months.
The Project Black Dot platform, which will unveil multiple initiatives throughout the coming year, will kick off today with “Project 1: Permission,” calling attention to current regulations on sunscreen in schools. This initiative will put the power into the hands of parents and schools by providing a simple, sunscreen permission slip which gives children the ability to use and apply sunscreen at school with the goal of obtaining 100,000 signed sunscreen permission slips.
To view the multimedia release go to:
http://www.multivu.com/players/English/7633051-supergoop-project-black-dot/
The St. Baldrick’s Foundation, a volunteer-powered charity dedicated to funding children’s cancer research, is recognizing National Childhood Cancer Awareness Month with a number of activities planned throughout September. As the leading non-governmental funder of childhood cancer research grants, St. Baldrick’s is asking people to get involved by helping to raise awareness and funds for childhood cancer research.
“One in five kids with cancer will die in the first five years of diagnosis, and those that do survive face a lifetime of serious health issues caused by the toxicity of their cure,” said Kathleen Ruddy, CEO of St. Baldrick’s. “The American public wants kids with cancer to be a national health priority, but our leaders are leaving these kids behind with the lack of federal research funding. We are calling upon everyone to speak up about the need for increased childhood cancer research funding as well as to stand up in support of kids with cancer during this important month.”
Today, as part of the official kickoff for Childhood Cancer Awareness Month, St. Baldrick’s will ring the opening bell at the NASDAQ Stock Market. St. Baldrick’s board members will be joined by researchers, as well as children and families directly affected by childhood cancer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7610751-st-baldricks-childhood-cancer-awareness-month/
